HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Elocalcitol

HCID 11396600
New reaction
Print
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
199798-84-0
Standard SMILES
C=C1/C(=C\C=C2/CCC[C@]3(C)C([C@@H](C)C/C=C/C(O)(CC)CC)=CC[C@@H]23)C[C@@H](O)C[C@@H]1F
InChIKey
LRLWXBHFPGSUOX-GJQYOBCGSA-N
Molecular formula
C29H43FO2
Average molar mass
442.6 g/mol
Monoisotopic mass
442.32470877

Overview

Elocalcitol is a calcitriol analog for inhibition of prostate cell growth; in phase II clinical trial in patients with benign prostate hyperplasia (4/2004).

Names & identifiers

Preferred name
Elocalcitol
IUPAC
trans-(1R,3Z,5S)-3-[(2E)-2-[(3aS,7aS)-1-[(E,2S)-6-ethyl-6-hydroxyoct-4-en-2-yl]-7a-methyl-3a,5,6,7-tetrahydro-3H-inden-4-ylidene]ethylidene]-5-fluoro-4-methylidenecyclohexan-1-ol
English name
ELOCALCITOL
Molecular formula
C29H43FO2
Molecular weight
442.65

Names & synonyms

Elocalcitol199798-84-0BXL 6282WDS5F2V6Q(1R,3Z,5S)-3-[(2E)-2-[(3aS,7aS)-1-[(E,2S)-6-ethyl-6-hydroxyoct-4-en-2-yl]-7a-methyl-3a,5,6,7-tetrahydro-3H-inden-4-ylidene]ethylidene]-5-fluoro-4-methylidenecyclohexan-1-olDTXSID10173774elocalcitolum(1R,3Z,5S)-3-((2E)-2-((3aS,7aS)-1-((E,2S)-6-ethyl-6-hydroxyoct-4-en-2-yl)-7a-methyl-3a,5,6,7-tetrahydro-3H-inden-4-ylidene)ethylidene)-5-fluoro-4-methylidenecyclohexan-1-olRefChem:590718DTXCID6096265(1R,3Z,5S)-3-(2-((3aS,7E,7aS)-3-((2S,4E)-6-ethyl-6-hydroxyoct-4-en-2-yl)-3a-methyl-3a,4,5,6,7,7a-hexahydro-1H-inden-7-ylidene)ethylidene)-5-fluoro-4-methylidenecyclohexan-1-olBXL-628
Show more names
Ellocalciferol(1R,3E,5S)-3-[(2E)-2-[(3aS,7aS)-1-[(E,2S)-6-ethyl-6-hydroxyoct-4-en-2-yl]-7a-methyl-3a,5,6,7-tetrahydro-3H-inden-4-ylidene]ethylidene]-5-fluoro-4-methylidenecyclohexan-1-olCyclohexanol, 3-[(2E)-2-[(3aS,7aS)-1-[(1S,3E)-5-ethyl-5-hydroxy-1-methyl-3-hepten-1-yl]-3,3a,5,6,7,7a-hexahydro-7a-methyl-4H-inden-4-ylidene]ethylidene]-5-fluoro-4-methylene-, (1R,3Z,5S)-

Properties

Computed structural properties

XLogP
5.7
Topological polar surface area
40.5 Ų
Hydrogen bond donors
2
Hydrogen bond acceptors
3
Rotatable bonds
7
Heavy atoms
32
Formal charge
0
Complexity
813

Experimental & physicochemical properties

DrugsPharmaceuticals -> Listed in ZINC15

Physicochemical properties

Boiling point
568.3 · 568.3±50.0 °C(Predicted)
Density
1.05 · 1.05±0.1 g/cm3(Predicted)
storage temp.
-20 °C · Store at -20°C
solubility
20 · Ethanol:20.0(Max Conc. mg/mL);45.18(Max Conc. mM)
form
A crystalline solid
pka
14.04 · 14.04±0.40(Predicted)
color
White to off-white
optical activity
97 to · [α]/D +97 to +107°, c =c=1 in methanol
InChIKey
LRLWXBHFPGSUOX-GJQYOBCGSA-N
SMILES
F[C@H]1C[C@@H](C\C(=C\C=C2\[C@H]3[C@](CCC\2)(C(=CC3)[C@H](C\C=C\C(O)(CC)CC)C)C)\C1=C)O
FDA UNII
2 WDS5F2V6Q · 2WDS5F2V6Q
Comptox DTXSID

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

Safety data

wgk
WGK 3
Storage Class
11 - Combustible Solids

Chemistry & industry

Applications · 2 items

DescriptionBXL-628 is an analog of vitamin D3 that has diverse biological activities. It increases death of androgen-stimulated human benign prostatic hyperplasia (BPH) cells via induction of apoptosis in a dose-dependent manner. In vivo, BXL-628 completely inhibits androgen-stimulated prostate overgrowth in a rat model of BPH. It reduces expression of IL-13 and IgE/mast cell-derived protease 1 (MMCP1) and decreases edema and leukocyte infiltration in the bladder wall in a mouse model of allergen-induced interstitial cystitis. BXL-628 also reduces the number of adherent endometrial stromal cells and decreases the total weight of endometrial lesions in a mouse model of endometriosis. Formulations containing BXL-628 are under clinical investigation for the treatment of BPH.

UsesElocalcitol (BXL-628) is a selective, orally active vitamin D receptor (VDR) agonist. Elocalcitol shows anti-inflammatory activity. Elocalcitol inhibits growth of prostate cancer cells[1][2].

Related reactions

0 records
New reaction record
No related reactions yet

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Elocalcitol [INN]Ro-26-9228Ro 26-9228BXL628UNII-2WDS5F2V6QC29H43FO2ELOCALCITOL [MART.]GTPL2785

Database identifiers

CAS
199798-84-0
PubChem CID
11396600
ChEMBL
CHEMBL3545094
UNII
2WDS5F2V6Q
Nikkaji
J3.510.012A
10173774 · DTXSID10173774
UNSPSC Code
12352200 · 12352200
NACRES
21 · NA.21
WGK Germany
3 · WGK 3
Storage Class
11 · 11 - Combustible Solids